Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
thioridazine alpha-1a adrenergic receptor small molecule NA drugbank , DGIDB Anxiety Disorders[MeSHID:D001008]
Schizophrenia[MeSHID:D012559]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.12 approved,withdrawn antagonist
thioridazine alpha-1b adrenergic receptor small molecule NA drugbank Anxiety Disorders[MeSHID:D001008]
Schizophrenia[MeSHID:D012559]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,withdrawn antagonist
thioridazine dopamine d1 receptor small molecule NA drugbank , DGIDB Anxiety Disorders[MeSHID:D001008]
Schizophrenia[MeSHID:D012559]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.1 approved,withdrawn antagonist
thioridazine dopamine d2 receptor small molecule Successful target TTD , drugbank , DGIDB Anxiety Disorders[MeSHID:D001008]
Schizophrenia[MeSHID:D012559]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.16 approved,withdrawn antagonist
thioridazine 5-hydroxytryptamine receptor 2a small molecule NA drugbank , DGIDB Anxiety Disorders[MeSHID:D001008]
Schizophrenia[MeSHID:D012559]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.2 approved,withdrawn antagonist
thioridazine potassium voltage-gated channel subfamily h member 2 small molecule NA drugbank , DGIDB Anxiety Disorders[MeSHID:D001008]
Schizophrenia[MeSHID:D012559]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.03 approved,withdrawn inhibitor
click here to return to the previous page